Incomplete Data in Cutaneous Squamous Cell Carcinoma Staging System Analysis

Anokhi Jambusaria-Pahlajani¹, Pritesh S Karia², Chrysalyne D Schmults^{2

3

4}

Affiliations

¹ Division of Dermatology, University of Texas at Austin, Austin.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Dermatologic Surgery Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁴ Brigham and Women's Faulkner Hospital, Jamaica Plain, Massachusetts.

Comment

Anokhi Jambusaria-Pahlajani et al. JAMA Dermatol. 2018.

. 2018 Dec 1;154(12):1488.

doi: 10.1001/jamadermatol.2018.4015.

Anokhi Jambusaria-Pahlajani¹, Pritesh S Karia², Chrysalyne D Schmults^{2

3

4}

¹ Division of Dermatology, University of Texas at Austin, Austin.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Dermatologic Surgery Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁴ Brigham and Women's Faulkner Hospital, Jamaica Plain, Massachusetts.

No abstract available

Comment in

Incomplete Data in Cutaneous Squamous Cell Carcinoma Staging System Analysis-Reply.
Roscher I, Falk RS. Roscher I, et al. JAMA Dermatol. 2018 Dec 1;154(12):1489. doi: 10.1001/jamadermatol.2018.4018. JAMA Dermatol. 2018. PMID: 30419117 No abstract available.

Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I, Falk RS, Vos L, Clausen OPF, Helsing P, Gjersvik P, Robsahm TE. Roscher I, et al. JAMA Dermatol. 2018 Apr 1;154(4):428-434. doi: 10.1001/jamadermatol.2017.6428. JAMA Dermatol. 2018. PMID: 29516080 Free PMC article.